FNT
IBB icon

First Nebraska Trust’s iShares Biotechnology ETF IBB Stock Holding History

First Nebraska Trust’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$279K Sell
1,654
-96
-5% -$16.4K 0.03% 192
2025
Q4 		$295K Sell
1,750
-87
-5% -$14.1K 0.03% 180
2025
Q3 		$265K Sell
1,837
-80
-4% -$10.9K 0.02% 179
2025
Q2 		$243K Hold
1,917
– – 0.02% 181
2025
Q1 		$245K Sell
1,917
-154
-7% -$20.9K 0.02% 179
2024
Q4 		$274K Sell
2,071
-65
-3% -$9.14K 0.03% 170
2024
Q3 		$311K Sell
2,136
-15
-0.7% -$2.17K 0.03% 162
2024
Q2 		$295K Sell
2,151
-75
-3% -$10K 0.03% 159
2024
Q1 		$305K Sell
2,226
-243
-10% -$33.2K 0.03% 153
2023
Q4 		$335K Sell
2,469
-189
-7% -$23.1K 0.04% 140
2023
Q3 		$325K Sell
2,658
-9,843
-79% -$1.25M 0.04% 137
2023
Q2 		$1.59M Sell
12,501
-156
-1% -$20.3K 0.19% 79
2023
Q1 		$1.63M Sell
12,657
-32
-0.3% -$4.19K 0.21% 76
2022
Q4 		$1.67M Sell
12,689
-3
-0% -$388 0.22% 75
2022
Q3 		$1.48M Sell
12,692
-202
-2% -$25.1K 0.21% 76
2022
Q2 		$1.52M Buy
12,894
+220
+2% +$26.1K 0.2% 76
2022
Q1 		$1.65M Buy
12,674
+392
+3% +$51.1K 0.2% 77
2021
Q4 		$1.87M Buy
12,282
+247
+2% +$38.2K 0.23% 68
2021
Q3 		$1.95M Buy
12,035
+291
+2% +$49K 0.25% 65
2021
Q2 		$1.92M Buy
11,744
+713
+6% +$110K 0.25% 66
2021
Q1 		$1.66M Buy
11,031
+400
+4% +$63.5K 0.22% 68
2020
Q4 		$1.61M Buy
10,631
+428
+4% +$61.2K 0.23% 65
2020
Q3 		$1.38M Buy
10,203
+1,274
+14% +$173K 0.24% 66
2020
Q2 		$1.22M Buy
+8,929
New +$1.14M 0.23% 70

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Nebraska Trust's IBB Position: Q1 2026 in Review

First Nebraska Trust reduced its iShares Biotechnology ETF (IBB) stake by 5.5% in Q1 2026, selling an estimated $16.4K and leaving 1,654 shares worth $279K. The position accounts for 0.03% of the portfolio, ranked #192.

First Nebraska Trust first reported a position in IBB in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.95M in Q3 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • First Nebraska Trust held 1,654 shares of iShares Biotechnology ETF worth $279K as of Q1 2026.
  • First Nebraska Trust sold 96 iShares Biotechnology ETF shares in Q1 2026, an estimated $16.4K.
  • iShares Biotechnology ETF made up 0.03% of First Nebraska Trust's portfolio in Q1 2026, its #192 holding.
  • First Nebraska Trust first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 24 quarters since.
  • First Nebraska Trust's iShares Biotechnology ETF position peaked at $1.95M in Q3 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.